EGFR and breast cancer: For example, miR-145 negatively regulates MUC1 and suppresses invasion and metastasis of breast cancer cells (55), and miR-145 suppresses proliferation, metastasis, and EMT of colorectal cancer via suppressing the EGFR-associated signaling pathway (56–58).